Search - tctmd.com

Displaying 101 - 120 of 199

Sort: Relevancy | Date

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

Presentation TCT 2016

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Gregg W. Stone, Philippe Pibarot, Susheel K. Kodali

November 01, 2016

Presentation TCT 2016

Debate: TAVR for Low Risk Patients Is It time? YES, the Data Is Sufficient and Our Patients Want It!

Presenter: Russell A. Brandwein, Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Case #5: Suboptimal Transcatheter Treatment of Failed Prior Surgical Mitral Repair

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Vinayak Bapat

October 30, 2016

Presentation TCT 2016

Case #4: Transseptal Transcatheter Treatment of Failed Mitral Bioprosthesis (With Tips and Tricks)

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Christian Spies

October 30, 2016

Presentation TCT 2016

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented?

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Isaac George

October 30, 2016

Presentation TCT 2016

Case #2: Transcatheter Valve-in-Valve in a Patient With a Small Aortic Bioprosthesis: Optimizing Hemodynamics

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Vasilis Babaliaros

October 30, 2016

Presentation TCT 2016

Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Hasan Jilaihawi

October 30, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

Presentation Fellows 2016

The TAVR Revolution: The Future of Aortic Stenosis Therapy

Presenter: Mark Reisman, Susheel Kodali

April 17, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Daily News

第 12 个月时女性的经导管主动脉瓣结局优于男性

Shelley Wood

February 23, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Shelley Wood

February 23, 2016

Presentation Scripps 2016

Valve-in-Valve Therapy for Failed Surgical Bioprosthetic Valves: Clinical Results and Procedural Approach

Presenter: Susheel K. Kodali

February 03, 2016

Presentation Scripps 2016

New Transcatheter Therapies: What Is Next On The Horizon?

Presenter: Susheel K. Kodali

February 02, 2016

Presentation TCT 2015

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Isaac George, Augusto D. Pichard, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Susheel Kodali

October 15, 2015

Advertisement

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Debate: TAVR for Low Risk Patients Is It time? YES, the Data Is Sufficient and Our Patients Want It!

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Case #5: Suboptimal Transcatheter Treatment of Failed Prior Surgical Mitral Repair

Case #4: Transseptal Transcatheter Treatment of Failed Mitral Bioprosthesis (With Tips and Tricks)

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented?

Case #2: Transcatheter Valve-in-Valve in a Patient With a Small Aortic Bioprosthesis: Optimizing Hemodynamics

Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

The TAVR Revolution: The Future of Aortic Stenosis Therapy

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

第 12 个月时女性的经导管主动脉瓣结局优于男性

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Valve-in-Valve Therapy for Failed Surgical Bioprosthetic Valves: Clinical Results and Procedural Approach

New Transcatheter Therapies: What Is Next On The Horizon?

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content